ArticleFrontiers in medicine2026
Clinical features of intestinal tuberculosis: an analysis of 46 cases, including six initially misdiagnosed as Crohn's disease.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: The purpose of this study was to summarize the clinical, laboratory, endoscopic, imaging, and histopathological features of intestinal tuberculosis (ITB), with a focus on the clinical characteristics of ITB cases initially misdiagnosed as Crohn's disease (CD), to improve clinicians' understanding and diagnosis of ITB. Methods: The clinical data of patients diagnosed with ITB at the First Affiliated Hospital of Wannan Medical University between 1 January 2012 and 31 December 2025 were retrospectively analyzed. Among them, six patients were initially misdiagnosed as having CD and were analyzed as a separate subgroup. All data were analyzed using descriptive statistical methods. Results: In total, 46 patients with ITB were enrolled in the study. The most common clinical manifestation was abdominal pain (32 cases, 69.56%), followed by abdominal distention (18 cases, 39.13%). The positive rates of the T-Spot assay for tuberculosis (T-SPOT.TB test), purified protein-derived (PPD) test, and chest imaging were 81.25% (26/32), 40.91% (9/22), and 39.13% (18/46), respectively. In the subgroup of six patients with ITB initially misdiagnosed as CD, all six underwent PPD and T-SPOT.TB testing, with positive rates of 50% and 100%, respectively, indicating 50% agreement between the two diagnostic methods. Because ITB could not be ruled out, all six patients received diagnostic antituberculosis therapy and showed a favorable response. Conclusion: The clinical manifestations of ITB lack specificity, and its endoscopic and imaging manifestations are diverse, making ITB easily confused with CD. In patients with a high clinical suspicion of ITB, diagnostic antituberculosis treatment can serve as an important auxiliary diagnostic method. Improving the recognition of atypical ITB cases may help reduce misdiagnosis and improve patient prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.